Answers are grounded in this paper and cite their sources.
The author calls for rigorous, carefully designed evaluation of intracoronary fibrinolytic therapy for acute myocardial infarction before widespread adoption.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Muller et al. (1981) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: